These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 19749671

  • 21. Do screening-preventative interventions in asymptomatic pregnancies reduce the risk of preterm delivery--a critical appraisal of the literature.
    Varma R, Gupta JK, James DK, Kilby MD.
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):145-59. PubMed ID: 16517046
    [Abstract] [Full Text] [Related]

  • 22. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW, Lee PA, Zachary AS, Calhoun S, Migeon CJ.
    Obstet Gynecol; 1979 Oct; 54(4):412-8. PubMed ID: 492618
    [Abstract] [Full Text] [Related]

  • 23. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO, Stamilio DM, Macones GA, Polsky D.
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [Abstract] [Full Text] [Related]

  • 24. Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.
    Lim AC, Bloemenkamp KW, Boer K, Duvekot JJ, Erwich JJ, Hasaart TH, Hummel P, Mol BW, Offermans JP, van Oirschot CM, Santema JG, Scheepers HC, Schöls WA, Vandenbussche FP, Wouters MG, Bruinse HW, AMPHIA study group.
    BMC Pregnancy Childbirth; 2007 Jun 19; 7():7. PubMed ID: 17578562
    [Abstract] [Full Text] [Related]

  • 25. The rebirth of progesterone in the prevention of preterm labor.
    Schmouder VM, Prescott GM, Franco A, Fan-Havard P.
    Ann Pharmacother; 2013 Apr 19; 47(4):527-36. PubMed ID: 23535817
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N, Khadem N, Mohajeri T, Shakeri MT.
    J Obstet Gynaecol Res; 2011 Oct 19; 37(10):1342-5. PubMed ID: 21564406
    [Abstract] [Full Text] [Related]

  • 27. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL, Kauppila A, Tuimala R.
    Obstet Gynecol; 1980 Dec 19; 56(6):692-5. PubMed ID: 7443111
    [Abstract] [Full Text] [Related]

  • 28. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct 19; 30(5):697-705. PubMed ID: 17899571
    [Abstract] [Full Text] [Related]

  • 29. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
    How HY, Barton JR, Istwan NB, Rhea DJ, Stanziano GJ.
    Am J Obstet Gynecol; 2007 Sep 19; 197(3):260.e1-4. PubMed ID: 17826411
    [Abstract] [Full Text] [Related]

  • 30. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
    Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.
    Am J Obstet Gynecol; 2008 Oct 19; 199(4):389.e1-4. PubMed ID: 18928983
    [Abstract] [Full Text] [Related]

  • 31. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
    Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S, National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2005 Sep 19; 193(3 Pt 2):1127-31. PubMed ID: 16157124
    [Abstract] [Full Text] [Related]

  • 32. Progestogen administration in pregnancy may prevent preterm delivery.
    Keirse MJ.
    Br J Obstet Gynaecol; 1990 Feb 19; 97(2):149-54. PubMed ID: 2138496
    [Abstract] [Full Text] [Related]

  • 33. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
    Winer N, Bretelle F, Senat MV, Bohec C, Deruelle P, Perrotin F, Connan L, Vayssière C, Langer B, Capelle M, Azimi S, Porcher R, Rozenberg P, Groupe de Recherche en Obstétrique et Gynécologie.
    Am J Obstet Gynecol; 2015 Apr 19; 212(4):485.e1-485.e10. PubMed ID: 25448515
    [Abstract] [Full Text] [Related]

  • 34. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].
    Rozenberg P.
    J Gynecol Obstet Biol Reprod (Paris); 2001 May 19; 30(3):221-30. PubMed ID: 11397997
    [Abstract] [Full Text] [Related]

  • 35. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC, Mol BW, Bruinse HW.
    Ned Tijdschr Geneeskd; 2010 May 19; 154():A1730. PubMed ID: 20858311
    [Abstract] [Full Text] [Related]

  • 36. Preterm labor in twins and high-order multiples.
    Elliott JP.
    Clin Perinatol; 2007 Dec 19; 34(4):599-609, vii. PubMed ID: 18063108
    [Abstract] [Full Text] [Related]

  • 37. Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention.
    Bandino JP, Thoppil J, Kennedy JS, Hivnor CM.
    Cutis; 2011 Nov 19; 88(5):241-3. PubMed ID: 22272488
    [Abstract] [Full Text] [Related]

  • 38. Preterm labour. Pharmacological prevention of prematurity.
    Groom KM.
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct 19; 21(5):843-56. PubMed ID: 17482517
    [Abstract] [Full Text] [Related]

  • 39. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth.
    Byrns MC.
    J Steroid Biochem Mol Biol; 2014 Jan 19; 139():173-81. PubMed ID: 23410596
    [Abstract] [Full Text] [Related]

  • 40. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.
    Sibai BM, Istwan NB, Palmer B, Stanziano GJ.
    Am J Perinatol; 2012 Sep 19; 29(8):635-42. PubMed ID: 22576126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.